Mail

Australia markets closed

ALL ORDS
7,269.80
-66.30(-0.90%)
AUD/USD
0.6579
-0.0043(-0.65%)
ASX 200
7,061.60
-63.10(-0.89%)
OIL
73.40
+0.36(+0.49%)
GOLD
2,054.20
+12.00(+0.59%)
Bitcoin AUD
63,245.94
+261.39(+0.41%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

8.20

+0.63

(+8.32%)

At close: 04:00PM EST

8.25

+0.05

(+0.61%)

After hours:

07:59PM EST

Currency in USD

Valuation measures⁴

Market cap (intra-day)	671.47M
Enterprise value	520.44M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	4.73
Enterprise value/revenue	N/A
Enterprise value/EBITDA	-11.18

Trading information

Stock price history

Beta (5Y monthly)	0.82
52-week change ³	-9.67%
S&P500 52-week change ³	16.58%
52-week high ³	11.93
52-week low ³	4.90
50-day moving average ³	6.17
200-day moving average ³	7.96

Share statistics

Avg vol (3-month) ³	1.02M
Avg vol (10-day) ³	1.35M
Shares outstanding ⁵	82.09M
Implied shares outstanding ⁶	82.09M
Float ⁸	79.5M
% held by insiders ¹	3.19%
% held by institutions ¹	33.90%
Shares short (14 Nov 2023) ⁴	18.12M
Short ratio (14 Nov 2023) ⁴	18.42
Short % of float (14 Nov 2023) ⁴	22.73%
Short % of shares outstanding (14 Nov 2023) ⁴	22.08%
Shares short (prior month 12 Oct 2023) ⁴	17.81M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:4
Last split date ³	06 Oct 2015

Financial highlights

Fiscal year

Fiscal year ends	29 Sept 2023
Most-recent quarter (mrq)	29 Sept 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-21.59%
Return on equity (ttm)	-33.41%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	N/A
Net income avi to common (ttm)	-47.51M
Diluted EPS (ttm)	-0.60
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	151.02M
Total cash per share (mrq)	1.84
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	12.32
Book value per share (mrq)	1.73

Cash flow statement

Operating cash flow (ttm)	-27.79M
Levered free cash flow (ttm)	-14.27M